Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

STEP-HFpEF

Novo Nordisk · Phase 3 · Completed · Enrollment 529

NCT04788511

EudraCT 2019-004452-11

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutiden/rn/rn/rn/rn/r
Placebo (semaglutide)7 participants3 participants10 participantsn/r4

A count stays a count. This page does not turn a count into a percent.